Altered expression of calreticulin during the development of fibrosis

Proteomics

Volumn 8, Issue 12, 2008, Pages 2407-2419

  Kypreou, Katerina P ^a   Kavvadas, Panagiotis ^a   Karamessinis, Panagiotis ^a   Peroulis, Michalis ^a   Alberti, Avra ^a   Sideras, Paschalis ^a   Psarras, Stelios ^a   Capetanaki, Yasemie ^a   Politis, Panagiotis K ^a   Charonis, Aristidis S ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Calreticulin; Epithelial to mesenchymal transition; Fibrosis; TGF b1

Indexed keywords

BLEOMYCIN; CALCIUM ION; CALRETICULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; FIBROSIS; HEART MUSCLE FIBROSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; UPREGULATION;

ANIMALS; BLEOMYCIN; CALRETICULIN; CELL LINE, TRANSFORMED; CELLS, CULTURED; COLLAGEN; DESMIN; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; PROTEOMICS; PULMONARY FIBROSIS; RATS; RATS, WISTAR; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; RATTUS;

EID: 48249132024     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700831     Document Type: Article

References (34)

1. Sime, P. J., O'Reilly, K. M., Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment. Clin. Immunol. 2001, 99, 308-319.
2. Wunn, T. A., Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 2007, 117, 524-529.
3. Kalluri, R., Neilson, E. G., Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112, 1776-1784.
4. Liu, Y., Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanisms, and therapeutic interventions. J. Am. Soc. Nephrol. 2004, 15, 1-12.
5. Klahr, S., Morrissey, J., Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 2002, 283, F861-F875.
6. Hoorn, E. J., Pisitkun, T., Zietse, R., Groos, P. et al., Prospects for urinary proteomics: Exosomes as a source of urinary biomarkers. Nephrology 2005, 10, 283-290.
7. Merchant, M. L., Klein, J. B., Proteomics and diabetic nephropathy. Curr. Diab. Rep. 2005, 5, 464-469.
8. O'Riordan, E., Gross, S. S., Goligorsky, M. S., Technology insight: Renal proteomics-at the crossroads between promise and problems. Nat. Clin. Pract. Nephrol. 2006, 2, 445-458.
9. Michalak, M., Corbett, E. F., Masaeli, N., Nakamura, K., Opas, M., Calreticulin: One protein, one gene, many functions. Biochem. J. 1999, 344, 281-292.
10. Michalak, M., Robert, J. M., Opas, M., Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 2002, 32, 269-278.
11. Zhang, J. X., Braakman, I., Matlack, K. E., Helenius, A., Quality control in the secretory pathway: The role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. Mol. Biol. Cell 1997, 8, 1943-1954.
12. 2+ binding to control of gene expression. Trends Cell Biol. 1994, 4, 152-154.
13. Harada, K., Okiyoneda, T., Hashimoto, Y., Ueno, K. et al., Calreticulin negatively regulates the cell surface expression of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 2006, 281, 12841-12848.
14. Izbicki, G., Segel, M. J., Christensen, T. G., Conner, M. W., Breuer, R., Time-course of bleomycin-induced lung fibrosis. Int. J. Exp. Pathol. 2002, 83, 111-119.
15. Milner, D. J., Weitzel, G., Tran, D., Bradlet, A., Capetanaki, Y., Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J. Cell Biol. 1996, 134, 1255-1270.
16. Mavroidis, M., Capetanaki, Y., Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy. Am. J. Pathol. 2002, 160, 943-952.
17. Ma, L.-J., Yang, H., Gaspert, A., Carlesso, G. et al., Transforming growth factor-β-dependent and -independent pathways of induction of tubulointerstitial fibrosis in β6-/-mice. Am. J. Pathol. 2003, 163, 1261-1273.
18. Ryan, M. J., Johnson, G., Kirk, J., Fuerstenberg, S. M. et al., HK-2: An immortalized proximal tubule epithelial cell line form normal adult human kidey. Kidney Int. 1994, 45, 48-57.
19. Wright, E. J., McCaffrey, T. A., Robertson, A. P., Vaughan, E. D., Jr., Felsen, D., Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta. Lab. Invest. 1996, 74, 528-537.
20. Ludewig, D., Kosmehl, H., Sommer, M., Bohmer, F. D., Stein, G., PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction. Cell Tissue Res. 2000, 299, 97-103.
21. Prieto, M., Rodrigez-Pena, A. B., Duwel, A., Rivas, J. V. et al., Temporal changes in renal endoglin and TGF-beta1 expression following ureteral obstruction in rats. J. Physiol. Biochem. 2005, 61, 457-467.
22. Michalak, M., Milner, R. E., Burns, K., Opas, M., Calreticulin. Biochem. J. 1992, 285, 681-692.
23. Strutz, F., Okada, H., Lo, C., Danoff, T. et al., Isolation and characterization of a marker for fibroblasts: FSP1. J. Cell Biol. 1995, 130, 393-405.
24. LeHir, M., Hegyi, I., Cueni-Loffing, D., Loffing, J., Kaissling, B., Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys. Histochem. Cell Biol. 2005, 123, 335-346.
25. Inoue, T., Plieth, D., Venkov, C. D., Xu, C., Neilson, E. G., Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int. 2005, 67, 2488-249.
26. Willis, B. C., duBois, R. M., Borok, Z., Epithelial origin of myofibroblasts during fibrosis of the lung. Proc. Am. Thor. Soc. 2006, 3, 377-382.
27. Wu, Z., Yang, L., Cai, L., Zhang, M. et al., Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an α-smooth muscle actin-Cre transgenic mouse. Respin Res. 2007, 8, 1-11.
28. Bakin, A. V., Rinehart, C., Tomlinson, A. K., Arteaga, C. L., p38 mitogen activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 2002, 115, 3193-3206.
29. Matsuoka, H., Arai, T., Mori, M., Goya, S. et al., A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283, L103-L112.
30. Yamazaki, T., Muramoto, M., Nishimura, S., Kita, Y., Suppressive effects of FR167653, an inhibitor of p38 mitogen-activated kinase, on calreticulin mRNA expression induced by endoplasmic reticulum stresses. Eur. J. Pharmacol. 2004, 484, 147-156.
31. Hayashida, Y., Urata, Y., Muroi, E., Kono, T. et al., Calreticulin represses E-cadherin gene expression in Madin-Darby canine kidney cells via slug. J. Biol. Chem. 2006, 281, 32469-32484.
32. Saleem, M., Kweon, M. H., Johnson, J. J., Adhami, V. M. et al., S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc. Nat. Acad. Sci. 2006, 103, 14825-14830.
33. Wu, M., Massaeli, H., Durston, M., Mesaeli, N., Differential expression and activity of matrix metalloproteinase-2 and -9 in the calreticulin deficient cells. Matrix Biol. 2007, 26, 463-472.
34. Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L. et al., Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13, 952-961.